Twitter Facebook LinkedIn

News & Events

FAQ Group Archives: Programs

SMART Surveillance Conducted by Merck Access Information: To access Merck’s SMART Surveillance program, submit a request for the SMART datasets to be redirected to the appropriate Merck website: SMART Surveillance Heatmaps SMART Surveillance data request Primary objective Global surveillance; resistance trend analysis; fulfilment of regulatory commitments.  

Bedaquiline Drug Resistance Assessment in MDR-TB (DREAM) Conducted by Johnson & Johnson Family of Companies Countries: India, Lithuania, Pakistan, Philippines, South Africa, South Korea, Taiwan, Thailand, Turkey, USA, Viet Nam Primary objective To determine the level of susceptibility of MDR-TB isolates to BDQ by the minimal inhibitory concentration (MIC) drug susceptibility testing (DST) methods.  

Global surveillance 2018-2020 Conducted by Venatorx Active: 2018-2020 Countries: Argentina, Australia, Belgium, Brazil, Canada, Chile, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, India, Ireland, Israel, Italy, Japan, Kuwait, Latvia, Lithuania, Malaysia, Mexico, Morocco, Netherlands, New Zealand, Nigeria, Panama, Philippines, Poland, Portugal, Puerto Rico, Romania,…

KEYSTONE Program Conducted by Paratek Active: 2014-2020 Countries: Austria, Belarus, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Netherlands, Norway, Poland, Portugal, Romania, Russia, Slovenia, Spain, Sweden, Switzerland, Turkey, UK, Ukraine, USA Primary Objective The Keystone Surveillance Program was designed to monitor omadacycline susceptibility over time while fulfilling post-marketing regulatory requirements. …

ATLAS (Antimicrobial Testing Leadership and Surveillance) Program Conducted by Pfizer Active: 2004 Onwards Countries: Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Cameroon, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Egypt, El Salvador, Estonia, Finland, France, Germany, Greece, Guatemala, Honduras, Hong Kong, Hungary, India, Indonesia, Ireland, Israel, Italy, Ivory Coast, Jamaica, Japan, Jordan,…

SOAR 201818 Program Conducted by GSK Active: 2014-2016 Countries: Romania, Bulgaria, Croatia, Serbia, Ukraine, Slovak Republic, Russia, Czech Republic, Greece Primary objective Data generation for antibiotic resistance of the main community-acquired respiratory tract infection pathogens such as S.pneumoniae and H.influenzae. Protocol Summary

SIDERO-WT Program Conducted by Shionogi Active: 2014-2019 Countries Canada, Czech Republic, France, Germany, Greece, Hungary, Italy, Russia, Spain, Sweden, Turkey, UK, USA Primary objective Annual evaluation of cefiderocol activities against US/EU Gram-negative isolates. To evaluate the antibacterial activity of cefiderocol and comparators against a wide variety of Gram-negative bacteria including carbapenem-resistant isolates.